Evidence map›Paper›PMID 35015241›Full record

ReviewCellular oncology (Dordrecht, Netherlands)2022

Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?

Martine Froukje van der Kamp, Gyorgy Bela Halmos, Victor Guryev, Peter Laszlo Horvatovich, Ed Schuuring, Bernardus Franciscus Augustinus Maria van der Laan, Bert van der Vegt, Boudewijn Evert Christiaan Plaat, Cornelia Johanna Verhoeven

Open access · greenAbstract readReview
In one paragraph

Review in Cellular oncology (Dordrecht, Netherlands), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. NJournal of cancer research and clinical oncology · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Martine Froukje van der KampDepartment of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700RB, Groningen, The Netherlands. m.f.van.der.kamp@umcg.nl.
Gyorgy Bela HalmosDepartment of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700RB, Groningen, The Netherlands.
Victor GuryevEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Peter Laszlo HorvatovichDepartment of Pharmacy, Analytical Biochemistry, University of Groningen, Groningen, The Netherlands.
Ed SchuuringDepartment of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Bernardus Franciscus Augustinus Maria van der LaanDepartment of Otorhinolaryngology and Head and Neck Surgery, Haaglanden Medical Center, The Hague, The Netherlands.
Bert van der VegtDepartment of Pathology & Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Boudewijn Evert Christiaan PlaatDepartment of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700RB, Groningen, The Netherlands.
Cornelia Johanna VerhoevenDepartment of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700RB, Groningen, The Netherlands.
University of Groningen · NLUniversity Medical Center Groningen · NLMedisch Centrum Haaglanden · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent clinical practice, an increasing number of elderly patients suffering from head and neck squamous cell carcinoma (HNSCC) of unknown pathophysiology is observed. The majority of HNSCC patients can roughly be divided into three subcategories. First, a small group of young patients who present with variants of genomic aberrations and inheritable diseases like Fanconi anaemia. Second, an increasing population of HPV-related HNSCCs that are regarded as genomic stable tumours with a more favourable prognosis. Though HPV-related tumours used to be more common among younger males, a notable rise in the elderly population is observed. The third subcategory, that of HPV-negative tumours, has been shown to be more heterogeneous with involvement of a variety of oncogenic pathways related to lifestyle factors like smoking and alcohol consumption, often seen in middle-aged males. Some of these pathways could be related to age, such as TP53 alterations, EGFR activation, apoptotic pathway alterations and field cancerization.

conclusionsIn this narrative review, we provide an overview of established and newly discovered age-specific pathophysiological mechanisms underlying HNSCC. We propose a fourth subcategory of patients with a suspected different pathophysiology: elderly (HPV-negative) HNSCC patients without a history of tobacco and alcohol consumption. In this subcategory, carcinogenesis seems to be a multi-step process based on genomic instability, immunosenescence, cell cycle disruption and telomere shortening. To conclude, we discuss suggestions for future research to fill the knowledge gap about age-dependent HNSCC carcinogenesis.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsPapillomavirus InfectionsAgedAge FactorsCarcinogenesisHumansMaleMiddle AgedPapillomaviridaeSquamous Cell Carcinoma of Head and NeckAgeingAge-specific factorsEpigeneticsHead and neck squamous cell carcinomaImmunosenescenceOncogenic pathwaysPathophysiologyTumour biology

Identifiers

PMID35015241
PMCPMC12978101
OpenAlexW4205273023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.